Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.

Journal of atherosclerosis and thrombosis - 1 Jan 2011

Tokura Takehiko, Itano Seiji, Kobayashi Shinya, Kuwabara Atsunori, Fujimoto Sohachi, Horike Hideyuki, Satoh Minoru, Komai Norio, Tomita Naruya, Matsunaga Akira, Saito Takao, Sasaki Tamaki, Kashihara Naoki

Abstract excerpt

Lipoprotein glomerulopathy (LPG) is a rare glomerulopathy caused by lipoprotein thrombi. In almost all cases of LPG, several apolipoprotein (apo) E mutations were reported. Here, we present a case of LPG caused by a novel mutation that we named ApoE2 Kurashiki, which substitutes arginine with proline at apoE codon 158. ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kidney Diseases
Share to Amino Acid Substitution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein E2

Share to Hyperlipoproteinemia Type III

Share to Kidney Glomerulus

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 21467726
DOI: 10.5551/jat.8102

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.PMID 21467726Read ↗

Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.Semantic proximity Read ↗

A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.Semantic proximity Read ↗

Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.Semantic proximity Read ↗

[Discovery of a Chinese Tibetan patient with lipoprotein glomerulopathy due to APOE Osaka/Kurashiki variant].Semantic proximity Read ↗

The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.Semantic proximity Read ↗

A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.Semantic proximity Read ↗

A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.Semantic proximity Read ↗

Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.Semantic proximity Read ↗

A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.Semantic proximity Read ↗

Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy.Semantic proximity Read ↗

Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.Semantic proximity Read ↗

<i>APOE</i>Kyoto Mutation in European Americans with Lipoprotein GlomerulopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.